CelSci (CVM)
(Delayed Data from AMEX)
$1.46 USD
-0.01 (-0.68%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $1.45 -0.01 (-0.68%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
CVM 1.46 -0.01(-0.68%)
Will CVM be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CVM based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for CVM
Cel-Sci Corp Bolsters Board with Finance Expert Mario Gobbo
CEL-SCI: LEAPS vaccine offers 'new paradigm to treat' RA published in Frontiers
CEL-SCI issues letter to shareholders regarding Multikine cancer therapy
Cel-Sci GAAP EPS of -$0.14
CEL-SCI Corp Talks Phase 3 Head and Neck Cancer Study, Immunotherapy for COVID-19 in Corporate ...